Literature DB >> 29564246

Antimicrobial resistance and putative virulence genes of Pseudomonas aeruginosa isolates from patients with respiratory tract infection.

Heba Y Al Dawodeyah1, Nathir Obeidat2, Luay F Abu-Qatouseh3, Asem A Shehabi4.   

Abstract

INTRODUCTION: Pseudomonas aeruginosa is a common agent causing community acquired and nosocomial respiratory tract infections, with particularly life-threatening manifestations in patients who are immunocompromised of who have cystic fibrosis. This study investigated the occurrence of extended-spectrum β-lactamases (ESBLs) and metallo β-lactamase (MBL) in association with important putative virulence genes and genotypes variation among P. aeruginosa isolates from respiratory tract infection of Jordanian patients.
METHODS: Over a period of 8-month, a total of 284 respiratory tract samples were obtained from patients diagnosed with respiratory tract infection while attending the Pulmonary Clinic/Intensive Care Unit, Jordan University Hospital (JUH). At the time of sampling most were inpatients (86.9%). Samples were cultured specifically for P. aeruginosa.
RESULTS: A total of 61/284 (21.5%) P. aeruginosa isolates were recovered from respiratory samples of patients. The percentage of MDR P. aeruginosa isolates was 52.5%, and all isolates were susceptible to colistin with lower rates of susceptibility to other tested antibiotics. Positive genes of blaCTX-M, blaVEB, blaTEM, blaGES and blaSHV were detected in 68.9%, 18.9%, 18.9%, 15.6% and 12.5% of isolates, respectively. Genotyping revealed no significant genetic relationship among MDR P. aeruginosa isolates from hospitalized patients as judged by the constructed dendrogram and the presence of 14 genotypic groups. The percentages of the virulence genes algD, lasB, toxA, exoS, and exoU among P. aeruginosa isolates were 98%, 98%, 80%, 33% and 33%, respectively, and 87% of isolates produced pyocyanin.
CONCLUSION: The present study demonstrates high occurrence of MDR P. aeruginosa isolates carrying blaCTX-M genes. No specific associations were found between antibiotic resistance, virulence genes and genotypes among MDR isolates.

Entities:  

Keywords:  Jordan patients; P. aeruginosa; antimicrobial resistance; respiratory infections; virulence factors

Year:  2018        PMID: 29564246      PMCID: PMC5845973          DOI: 10.18683/germs.2018.1130

Source DB:  PubMed          Journal:  Germs        ISSN: 2248-2997


  28 in total

1.  Emergence of KPC-producing Pseudomonas aeruginosa in the United States.

Authors:  Laurent Poirel; Patrice Nordmann; Emilie Lagrutta; Timothy Cleary; L Silvia Munoz-Price
Journal:  Antimicrob Agents Chemother       Date:  2010-04-26       Impact factor: 5.191

2.  Detection of extended-spectrum beta-lactamases in clinical isolates of Pseudomonas aeruginosa.

Authors:  Xiaofei Jiang; Zhe Zhang; Min Li; Danqiu Zhou; Feiyi Ruan; Yuan Lu
Journal:  Antimicrob Agents Chemother       Date:  2006-09       Impact factor: 5.191

3.  Spread of extended-spectrum β-lactamase genes of blaOXA-10, blaPER-1 and blaCTX-M in Pseudomonas aeruginosa strains isolated from burn patients.

Authors:  Zahra Farshadzadeh; Azar Dokht Khosravi; Seyed Mohammad Alavi; Najmeh Parhizgari; Hajar Hoveizavi
Journal:  Burns       Date:  2014-04-22       Impact factor: 2.744

4.  International study of the prevalence and outcomes of infection in intensive care units.

Authors:  Jean-Louis Vincent; Jordi Rello; John Marshall; Eliezer Silva; Antonio Anzueto; Claude D Martin; Rui Moreno; Jeffrey Lipman; Charles Gomersall; Yasser Sakr; Konrad Reinhart
Journal:  JAMA       Date:  2009-12-02       Impact factor: 56.272

Review 5.  Pseudomonas aeruginosa biofilm formation in the cystic fibrosis airway.

Authors:  Sophie Moreau-Marquis; Bruce A Stanton; George A O'Toole
Journal:  Pulm Pharmacol Ther       Date:  2008-01-29       Impact factor: 3.410

6.  Secretion of the toxin ExoU is a marker for highly virulent Pseudomonas aeruginosa isolates obtained from patients with hospital-acquired pneumonia.

Authors:  Grant S Schulert; Heather Feltman; Shira D P Rabin; Ciara G Martin; Scott E Battle; Jordi Rello; Alan R Hauser
Journal:  J Infect Dis       Date:  2003-11-21       Impact factor: 5.226

7.  Genetic features of clinical Pseudomonas aeruginosa strains.

Authors:  Katarzyna Wolska; Piotr Szweda
Journal:  Pol J Microbiol       Date:  2009

8.  Molecular identification and detection of virulence genes among Pseudomonas aeruginosa isolated from different infectious origins.

Authors:  V S Nikbin; M M Aslani; Z Sharafi; M Hashemipour; F Shahcheraghi; G H Ebrahimipour
Journal:  Iran J Microbiol       Date:  2012-09

9.  Genetic features of Pseudomonas aeruginosa isolates from cystic fibrosis patients compared with those of isolates from other origins.

Authors:  Philippe Lanotte; Stephane Watt; Laurent Mereghetti; Nathalie Dartiguelongue; Aziz Rastegar-Lari; Alain Goudeau; Roland Quentin
Journal:  J Med Microbiol       Date:  2004-01       Impact factor: 3.196

Review 10.  Pseudomonas Exotoxin A: optimized by evolution for effective killing.

Authors:  Marta Michalska; Philipp Wolf
Journal:  Front Microbiol       Date:  2015-09-15       Impact factor: 5.640

View more
  11 in total

Review 1.  Role of Host and Bacterial Lipids in Pseudomonas aeruginosa Respiratory Infections.

Authors:  Pamella Constantino-Teles; Albane Jouault; Lhousseine Touqui; Alessandra Mattos Saliba
Journal:  Front Immunol       Date:  2022-07-04       Impact factor: 8.786

2.  Antibiogram profile and virulence signatures of Pseudomonas aeruginosa isolates recovered from selected agrestic hospital effluents.

Authors:  Q Mapipa; T O Digban; N E Nnolim; U U Nwodo
Journal:  Sci Rep       Date:  2021-06-03       Impact factor: 4.379

Review 3.  Epidemiology of Multidrug-Resistant Pseudomonas aeruginosa in the Middle East and North Africa Region.

Authors:  Mahmood Al-Orphaly; Hamad Abdel Hadi; Faiha Kamaleldin Eltayeb; Hissa Al-Hail; Bincy Gladson Samuel; Ali A Sultan; Sini Skariah
Journal:  mSphere       Date:  2021-05-19       Impact factor: 4.389

4.  Coordination of las regulated virulence factors with Multidrug-Resistant and extensively drug-resistant in superbug strains of P. aeruginosa.

Authors:  Sanaz Dehbashi; Mohammad Reza Pourmand; Mohammad Yousef Alikhani; Sara Soleimani Asl; Mohammad Reza Arabestani
Journal:  Mol Biol Rep       Date:  2020-05-30       Impact factor: 2.742

5.  Molecular Epidemiology of Carbapenemase-Producing Pseudomonas aeruginosa Isolated from an Iranian University Hospital: Evidence for Spread of High-Risk Clones.

Authors:  Solmaz Ohadian Moghadam; Davoud Afshar; Mohammad Reza Nowroozi; Amir Behnamfar; Amirreza Farzin
Journal:  Infect Drug Resist       Date:  2020-06-03       Impact factor: 4.003

6.  Virulence Factors Of Carbapenem-Resistant Pseudomonas aeruginosa In Hospital-Acquired Infections In Mansoura, Egypt.

Authors:  Rasha El-Mahdy; Ghada El-Kannishy
Journal:  Infect Drug Resist       Date:  2019-11-07       Impact factor: 4.003

7.  Prevalence of the Genes Associated with Biofilm and Toxins Synthesis amongst the Pseudomonas aeruginosa Clinical Strains.

Authors:  Tomasz Bogiel; Dagmara Depka; Mateusz Rzepka; Joanna Kwiecińska-Piróg; Eugenia Gospodarek-Komkowska
Journal:  Antibiotics (Basel)       Date:  2021-02-28

8.  Molecular Mechanism of the β-Lactamase Mediated β-Lactam Antibiotic Resistance of Pseudomonas aeruginosa Isolated From a Chinese Teaching Hospital.

Authors:  Hailong Lin; Chunlin Feng; Tingting Zhu; Anqi Li; Shuang Liu; Lei Zhang; Qiaoling Li; Xueya Zhang; Li Lin; Junwan Lu; Xi Lin; Kewei Li; Hailin Zhang; Teng Xu; Changchong Li; Qiyu Bao
Journal:  Front Microbiol       Date:  2022-04-28       Impact factor: 5.640

9.  Efficacy of Ethanolic Extract of Syzygium aromaticum in the Treatment of Multidrug-Resistant Pseudomonas aeruginosa Clinical Isolates Associated with Urinary Tract Infections.

Authors:  Osama Ahmed; Hassan Mohamed; Wesam Salem; Magdy Afifi; Yuanda Song
Journal:  Evid Based Complement Alternat Med       Date:  2021-06-15       Impact factor: 2.629

10.  Virulence Constitution of Multi-Drug-Resistant Pseudomonas aeruginosa in Upper Egypt.

Authors:  Noha A Hassuna; Sahar A Mandour; Ebtisam Samir Mohamed
Journal:  Infect Drug Resist       Date:  2020-02-19       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.